Juvenescence: Think aging up, rather than disease down May 24, 2023 New CEO set to Marshall longevity with a pipeline that delivers immediate therapeutic benefit, but always has an eye on a future preventative angle. Back in January, we reported that...
Morphoceuticals raises $8m to advance electroceutical approach to regenerative medicine February 15, 2023 Biotech company Morphoceuticals has announced it closed an $8 million Seed-2 funding round led by Prime Movers Lab and initial investor Juvenescence. Seed funding will advance programs using electroceuticals in limb regeneration and...
Health: 3 Ways to Help Out Your Metabolism February 15, 2023 Juvenescence sponsored this article in Health, which discusses how your body can benefit from an efficient metabolism.
M2Bio Sciences Interview: Dr. Greg Bailey Goes Deep on Juvenescence, Longevity Biotech, and His Personal Story February 15, 2023 Dr. Greg Bailey, MD, CEO of Juvenescence, conducts an interview with M2Bio Sciences. In the interview, Greg shares his insights on Juvenescence, longevity biotech, entrepreneurship, and his personal story.
Longevity Technology: ‘Exclusive profile: LyGenesis and growing ectopic organs’ February 15, 2023 Michael Hufford, CEO of LyGenesis, speaks with Longevity Technology about revolutionary regenerative technology and plans for clinical development.
Barclays: ‘New Advances in the Biology of Aging’ February 15, 2023 Jim Mellon, Chairman of Juvenescence, speaks with Barclays as part of the ‘Beyond 100’ program, about the science of longevity and the implications of living until 120 years.
Longevity Technology: 'Juvenescence CEO on near-term Longevity breakthroughs February 15, 2023 Dr. Greg Bailey, MD gives an interview to Longevity Technology on near-term longevity breakthroughs, including the latest developments at Juvenescence and dealing with the impact of COVID-19.
Longevity Technology: ‘Relation-Mila collaboration wins $1.3m Gates Foundation Award to fight COVID-19’ February 15, 2023 Relation Therapeutics and Mila, the Montreal-based AI research institute are collaborating on a new project targeting the development of COVID-19 therapeutics funded by the Bill & Melinda Gates Foundation.
Longevity Technology: 'Hufford interview: "It’s worth pointing out just how remarkable this is."' February 15, 2023 LyGenesis CEO Michael Hufford talks to Longevity Technology about Longevity research programs and investment.
Hill Dickinson: Interview with Colin Watts, JuvLife CEO, about ketones, ketone metabolism research, and Metabolic Switch February 15, 2023 MDI’s expertise will help fight coronary heart disease, thrombosis, and chronic fibrotic and inflammatory diseases.
Longevity Technology: Equity investment in MDI Therapeutics by Juvenescence will develop novel serpin-based therapies February 15, 2023 MDI’s expertise will help fight coronary heart disease, thrombosis, and chronic fibrotic and inflammatory diseases.
MBG: An Expert Answers The Most Important Questions About Ketosis & Fasting February 15, 2023 Ketosis is featured in wellness conversations—from immunity to brain function to longevity. MGB talks ketosis with Dr. Brianna Stubbs, DPhil, scientist who helped develop the breakthrough ketone ester drink Metabolic...
